Business & Industry

CordenPharma, a global contract development and manufacturing organization specializing in complex drug modalities, has officially entered into an agreement to acquire AmbioPharm. The AmbioPharm Deal strengthens the company’s manufacturing presence in the United States while adding newly integrated production...

MSD and Adcendo have established a collaboration and supply agreement to evaluate the combination of ADCE-T02 and pembrolizumab. The companies are preparing for a Phase Ib solid tumour clinical trial targeting patients with advanced solid tumours. Adcendo will act as...

Chemspec Europe returned to Cologne on 6–7 May 2026, bringing together professionals from across the speciality chemicals sector despite ongoing economic and regulatory challenges facing the industry. The event welcomed 4,238 attendees representing 60 nations and featured 454 exhibitors...

After a seven-year absence from the sector, Eli Lilly is returning to the field through a trio of corporate purchases valued at more than $3.8 billion. This infectious disease M&A activity secures Curevo, LimmaTech Biologics, and Vaccine Company, firmly...

The U.S. Food and Drug Administration (FDA) has granted approval for Gilead Sciences's Hepcludex, an experimental drug designed to treat chronic hepatitis delta virus (HDV). This rare and severe liver disease, which exclusively affects individuals already living with hepatitis...

Bristol Myers Squibb has entered into a strategic agreement with Anthropic to deploy its Claude platform across global operations. This initiative moves beyond standard conversational tools, aiming to embed agentic AI capabilities directly into core workflows, including research, clinical...

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on a proposed Rare Disease Therapies Framework a regulatory proposal that would introduce a new development and authorisation pathway for therapies targeting rare diseases in the...